Crown Bioscience Inc (6554):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Crown Bioscience Inc (6554) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7858
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:台湾
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Crown Bioscience Inc (Crown Bioscience) is a drug discovery company that provides drug discovery and development services. The company offers antibodies, proteins, cell lines, tumor samples, in vivo and in vitro research reagents. It offers services such as preclinical research services, oncology services, and metabolic disease services, among others. Crown Bioscience provides its preclinical research services in areas of oncology and metabolic disease. The company’s oncology services comprise human surrogate trials, oncology databases, ex vivo services, in vitro services, in vivo services, translational research, preclinical formulations, and drug discovery services. Its metabolic disease services include CVMD databases, and ex vivo services. The company has its operations in the US, China, the UK, and Taiwan. Crown Bioscience is headquartered in Taipei, Taiwan.

Crown Bioscience Inc (6554) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Crown Bioscience Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Crown Bioscience Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Crown Bioscience Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Crown Bioscience Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Crown Bioscience Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Crown Bioscience Inc, Medical Equipment, Deal Details 10
Partnerships 10
Crown Bioscience Enters Into Agreement With Horizon Discovery To Develop In Vivo Models For Drug Discovery 10
Crown Bioscience Enters Into Co-Development Agreement With Horizon Discovery 11
Equity Offering 12
Crown Bioscience Raises USD20.8 Million in Public Offering of Shares 12
Acquisition 13
JSR Acquires Crown Bioscience for USD399.7 Million 13
Crown Bioscience Acquires PreClinOmics 15
Crown Bioscience Inc – Key Competitors 16
Crown Bioscience Inc – Key Employees 17
Crown Bioscience Inc – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Strategy And Business Planning 19
Jul 13, 2017: Crown Bioscience Expands its Life Science Portfolio 19
Jan 26, 2017: CrownBio Announces Expansion of Life Science Division 20
Financial Announcements 21
Aug 10, 2017: Crown Bioscience Announces Second Quarter Results 21
May 19, 2017: Crown Bioscience Announces Record Breaking Growth With First 2017 Quarter Results 22
Corporate Communications 23
Jun 06, 2018: Laurie Heilmann Named President of New CrownBio Global Life Science and Diagnostic Solutions Division 23
Nov 09, 2017: Crown Bioscience Announcing the 2017 Board of Directors Election Results Dr. Guoliang Yu re-elected as the Chairman 24
Sep 27, 2017: Crown Bioscience Names Laurie Heilmann Chief Business Officer; Executive Leader Brings Expertise in Global Strategy and Commercial Leadership to the Role 25
Aug 22, 2017: Crown Bioscience Names Dr. Leon Hall Vice President of Global Scientific Excellence 26
Aug 10, 2017: Crown Bioscience Appoints Dr. Yangzhou Wang as Sr. VP of Global Operations 27
Product News 28
Feb 27, 2018: Webinar to Reveal Data Supporting the Use of MuScreen for Preclinical Immunotherapeutic Development 28
Nov 23, 2017: Crown Bioscience and Data Sciences International (DSI) Partner to Advance Metabolic Disease Research Using an Implanted Telemetry Device for Long-Term Blood Glucose Monitoring 29
Jun 01, 2017: Crown Bioscience Showcases Dramatic Proficiency in PDX Models and Emerging Expertise in Immune-Oncology 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
Crown Bioscience Inc, Medical Equipment, Key Facts, 2017 2
Crown Bioscience Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Crown Bioscience Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Crown Bioscience Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Crown Bioscience Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Crown Bioscience Inc, Deals By Market, 2012 to YTD 2018 8
Crown Bioscience Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Crown Bioscience Enters Into Agreement With Horizon Discovery To Develop In Vivo Models For Drug Discovery 10
Crown Bioscience Enters Into Co-Development Agreement With Horizon Discovery 11
Crown Bioscience Raises USD20.8 Million in Public Offering of Shares 12
JSR Acquires Crown Bioscience for USD399.7 Million 13
Crown Bioscience Acquires PreClinOmics 15
Crown Bioscience Inc, Key Competitors 16
Crown Bioscience Inc, Key Employees 17
Crown Bioscience Inc, Other Locations 18
Crown Bioscience Inc, Subsidiaries 18

List of Figures
Crown Bioscience Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Crown Bioscience Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Crown Bioscience Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Crown Bioscience Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Crown Bioscience Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Crown Bioscience Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Crown Bioscience Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Crown Bioscience Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Crown Bioscience Inc (6554):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • BaxterStorey Ltd:企業の戦略・SWOT・財務分析
    BaxterStorey Ltd - Strategy, SWOT and Corporate Finance Report Summary BaxterStorey Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Luxey International (Holdings) Limited (8041):企業の財務・戦略的SWOT分析
    Luxey International (Holdings) Limited (8041) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Alfa SAB de CV (ALFAA):石油・ガス:M&Aディール及び事業提携情報
    Summary Alfa SAB de CV (Alfa) is a diversified company that operates in the petrochemical, refrigerated food, lightweight solutions, telecommunication, and oil and gas sectors. Alfa develops and manufactures high technology aluminum components for the power train and body structure of automotive. It …
  • Unique Catering & Management Services Ltd:企業の戦略・SWOT・財務情報
    Unique Catering & Management Services Ltd - Strategy, SWOT and Corporate Finance Report Summary Unique Catering & Management Services Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Ingram Micro Inc.:企業の戦略・SWOT・財務情報
    Ingram Micro Inc. - Strategy, SWOT and Corporate Finance Report Summary Ingram Micro Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • SAE Towers Holdings LLC:企業の戦略的SWOT分析
    SAE Towers Holdings LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Petroleo Brasileiro S.A. (Petrobras):戦略・SWOT・企業財務分析
    Petroleo Brasileiro S.A. (Petrobras) - Strategy, SWOT and Corporate Finance Report Summary Petroleo Brasileiro S.A. (Petrobras) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • SpareBank 1 SMN:企業の戦略・SWOT・財務分析
    SpareBank 1 SMN - Strategy, SWOT and Corporate Finance Report Summary SpareBank 1 SMN - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Prima Meat Packers Ltd:企業の戦略・SWOT・財務分析
    Prima Meat Packers Ltd - Strategy, SWOT and Corporate Finance Report Summary Prima Meat Packers Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • UMW Holdings Berhad (UMW):石油・ガス:M&Aディール及び事業提携情報
    Summary UMW Holdings Bhd (UMW) is a diversified company. The company operates through its business divisions such as automotive, equipment, manufacturing and engineering, and oil and gas. Its automotive business manufactures, assembles, markets and distributes passenger cars and commercial vehicles. …
  • Deutsche Lufthansa AG:企業のM&A・事業提携・投資動向
    Deutsche Lufthansa AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Deutsche Lufthansa AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • WGL Holdings Inc (WGL)-石油・ガス分野:企業M&A・提携分析
    Summary WGL Holdings, Inc. (WGL) is an energy holding company that delivers natural gas, and provides energy-related products and services to customers. It also provides design-build energy efficient and sustainable solutions and water and energy-related infrastructure services. The company delivers …
  • Mundipharma International Ltd:企業の戦略的SWOT分析
    Mundipharma International Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Campanile UK Ltd:企業の戦略・SWOT・財務分析
    Campanile UK Ltd - Strategy, SWOT and Corporate Finance Report Summary Campanile UK Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Koch Enterprises, Inc.:企業の戦略的SWOT分析
    Koch Enterprises, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Impax Laboratories Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Impax Laboratories Inc (Impax) develops, manufactures and markets generic and branded pharmaceuticals. It offers solid dose and alternative dosage form generic drugs in a broad range of therapeutic areas; and proprietary branded pharmaceutical products for the treatment of central nervous sy …
  • Kyocera Corporation:企業の戦略・SWOT・財務情報
    Kyocera Corporation - Strategy, SWOT and Corporate Finance Report Summary Kyocera Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • AlloSource:企業の戦略的SWOT分析
    AlloSource - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Triangle Energy (Global) Ltd (TEG):企業の財務・戦略的SWOT分析
    Summary Triangle Energy (Global) Ltd (Triangle Energy), formerly Maverick Energy Ltd, is an oil and gas company that explores and produces oil and natural gas reserves. The company operates oil and gas assets such as Reid’s Dome and Pase Field. It holds working interest and operates the Production S …
  • New World Development Company Limited:企業の戦略・SWOT・財務分析
    New World Development Company Limited - Strategy, SWOT and Corporate Finance Report Summary New World Development Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆